Delayed antiandrogen withdrawal syndrome after discontinuation of bicalutamide.

@article{Cowan2015DelayedAW,
  title={Delayed antiandrogen withdrawal syndrome after discontinuation of bicalutamide.},
  author={Andrew J Cowan and Yoshio Inoue and Evan Y Yu},
  journal={Clinical genitourinary cancer},
  year={2015},
  volume={13 1},
  pages={e51-3}
}
The antiandrogen withdrawal (AAW) syndrome is an important first therapeutic maneuver for patients using an oral antiandrogen in combination with luteinizing hormone-releasing hormone therapy after progression of prostate cancer to a castration-resistant state. The clinical response, either a prostate-specific antigen (PSA) decline or improvement in… CONTINUE READING